Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.10K | 20.90K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.10K | 20.90K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 31.10K | 20.90K | -- | -- | -- |
| SG&A Expenses | 2.20M | 1.42M | 1.77M | 2.41M | 4.00M |
| Depreciation & Amortization | 29.70K | 11.00K | 11.30K | 41.50K | 38.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.17M | 1.45M | 1.82M | 2.48M | 4.12M |
| Operating Income | -2.14M | -1.43M | -1.82M | -2.48M | -4.12M |
| Income Before Tax | -2.01M | -2.57M | -1.80M | 2.82M | -126.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.01M | -2.57M | -1.80M | 2.82M | -126.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.01M | -2.57M | -1.80M | 2.82M | -126.73M |
| EBIT | -2.14M | -1.43M | -1.82M | -2.48M | -4.12M |
| EBITDA | -2.12M | -1.41M | -1.81M | -2.43M | -4.09M |
| EPS Basic | -0.44 | -0.82 | -0.61 | 1.00 | -57.57 |
| Normalized Basic EPS | -0.28 | -0.31 | -0.41 | -0.57 | -1.22 |
| EPS Diluted | -0.44 | -0.82 | -0.61 | 1.00 | -57.57 |
| Normalized Diluted EPS | -0.28 | -0.31 | -0.41 | -0.57 | -1.22 |
| Average Basic Shares Outstanding | 4.54M | 3.12M | 2.94M | 2.82M | 2.20M |
| Average Diluted Shares Outstanding | 4.54M | 3.12M | 2.94M | 2.82M | 2.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |